Abstract
Macrolactins are secondary metabolites mainly from marine microorganisms bearing a unique 24-membered lactone core structure. Since their first occurrence in 1989, they have attracted considerable attention from natural product chemists, organic chemists, and pharmacologists due to their chemical complexity, potent antimicrobial and antitumor activities. Some of them are serving as lead compounds for drug discovery. Although a number of synthetic approaches have been developed, sample supply remains a big issue which precludes further investigation of pharmacological application and mechanisms of action. This review summarizes current knowledge about macrolactins including their chemical diversity, biological activities, synthetic studies, and efficient preparation.
Keywords: Antibiotic, antitumor, chemical diversity, efficient preparation, macrolactins, synthesis.
Graphical Abstract
Current Organic Chemistry
Title:Macrolactins: Antitumor Antibiotics as Marine Drug Lead
Volume: 18 Issue: 7
Author(s): Tingting Wang, Shan He, Xiaojun Yan and Peng Zhu
Affiliation:
Keywords: Antibiotic, antitumor, chemical diversity, efficient preparation, macrolactins, synthesis.
Abstract: Macrolactins are secondary metabolites mainly from marine microorganisms bearing a unique 24-membered lactone core structure. Since their first occurrence in 1989, they have attracted considerable attention from natural product chemists, organic chemists, and pharmacologists due to their chemical complexity, potent antimicrobial and antitumor activities. Some of them are serving as lead compounds for drug discovery. Although a number of synthetic approaches have been developed, sample supply remains a big issue which precludes further investigation of pharmacological application and mechanisms of action. This review summarizes current knowledge about macrolactins including their chemical diversity, biological activities, synthetic studies, and efficient preparation.
Export Options
About this article
Cite this article as:
Wang Tingting, He Shan, Yan Xiaojun and Zhu Peng, Macrolactins: Antitumor Antibiotics as Marine Drug Lead, Current Organic Chemistry 2014; 18 (7) . https://dx.doi.org/10.2174/138527281807140515144549
DOI https://dx.doi.org/10.2174/138527281807140515144549 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Protein Microarrays for Studies of Drug Mechanisms and Biomarker Discovery in the Era of Systems Biology
Current Pharmaceutical Design Novel Superactive Leptin Antagonists and their Potential Therapeutic Applications
Current Pharmaceutical Design Cinnamic Acid Derivatives Induce Cell Cycle Arrest in Carcinoma Cell Lines
Medicinal Chemistry Glycogen Synthase Kinase-3 (GSK-3) Inhibitors as a New Lead for Treating Breast and Ovarian Cancer
Current Drug Targets Cancer Treatment-Induced Cardiotoxicity: a Cardiac Stem Cell Disease?
Cardiovascular & Hematological Agents in Medicinal Chemistry Bioactive Compounds of <i>Polygonatum sibiricum</i> - Therapeutic Effect and Biological Activity
Endocrine, Metabolic & Immune Disorders - Drug Targets Effects and Role of Multikinase Inhibitors in Thyroid Cancer
Current Pharmaceutical Design The Clinical Applications of Heat Shock Protein Inhibitors in Cancer - Present and Future
Current Cancer Drug Targets Structural Aspects of Crystalline Derivatized Cyclodextrins and Their Inclusion Complexes
Current Organic Chemistry Editorial: [Cytokines as Anti-Cancer Agents Rational, Results and Perspectives (Guest Editor: S. Mocellin)]
Current Medicinal Chemistry Development and Engineering of Lymphatic Endothelial Cells: Clinical Implications
Current Pharmaceutical Design Drug Resistance in Hepatoblastoma
Current Pharmaceutical Biotechnology Resveratrol-Mediated Reversal of Tumor Multi-Drug Resistance
Current Drug Metabolism ING Proteins as Potential Anticancer Drug Targets
Current Drug Targets Heterocyclic Chalcone Analogues as Potential Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry The LPS-Pretreated MSCs Supply a Positive Microenvironment for Tumor Cell Proliferation and Clone Formation
Current Protein & Peptide Science Intestinal Absorption and Presystemic Elimination of Various Chemical Constituents Present in GBE50 Extract, a Standardized Extract of Ginkgo biloba Leaves
Current Drug Metabolism Synthesis and Biological Evaluation of Triazole-Vanillin Molecular Hybrids as Anti-Cancer Agents
Current Bioactive Compounds P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives
Current Cancer Drug Targets Bacterial Toxins: Potential Weapons Against HIV Infection
Current Pharmaceutical Design